Displaying 1 to 20 of 22 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Aclara Biosciences Inc Develops and distributes assay solutions for drug discovery and development |
United States | N/A Active |
||
|
|
Acorda Therapeutics Inc A biotechnology company whose mission is to develop and market therapeutic products for spinal cord injury and other central nervous system disorders. |
United States | N/A Active |
||
|
|
Addex Pharmaceuticals SA Switzerland-based drug company focused on CNS disorders |
Switzerland | N/A Active |
||
|
Aderis Pharmaceuticals Inc Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Artisan Pharma Inc Provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the United States and internationally. |
United States | 1 Sep 2006 | Series A Active |
|
|
|
Artisan Pharma Inc Provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the United States and internationally. |
United States | 1 Mar 2010 | Series B Active |
|
|
|
Artisan Pharma Inc Provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the United States and internationally. |
United States | Series C Active |
||
|
|
Codexis Inc Engages in the production of custom industrial enzymes for use in the manufacture of biofuels, chemicals, and pharmaceutical ingredients. |
United States | 1 Aug 2006 | Series D |
|
|
|
Five Prime Therapeutics Inc |
United States | N/A |
||
|
Fluidigm Corp Developer and manufacturer of microfluidic systems for markets in the life science and agricultural biotechnology industries. |
United States | 1 Jan 2007 | Series E Active |
|
|
|
Forma Therapeutics Inc |
United States | N/A |
||
|
|
Inotek Pharmaceuticals Corp Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. |
United States | N/A |
||
|
Ironwood Pharmaceuticals Inc Entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. |
United States | N/A |
||
|
|
Kadmus Pharmaceuticals Inc Biopharmaceutical company developing therapeutics for the treatment of pain, obesity, and other unmet medical needs. |
United States | N/A |
||
|
|
KaloBios Pharmaceuticals Inc Develops first- or best-in-class antibody therapeutics in the fields of autoimmunity |
United States | N/A |
||
|
|
Panomics Inc Develops novel cell-based assays and tools to enable multiplexed measurements of molecular events in a quantitative and scalable manner |
United States | N/A |
||
|
|
Raven Biotechnologies Inc A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. |
United States | N/A |
||
|
|
Renovis Inc |
United States | N/A |
||
|
|
S*Bio Pte Ltd Singapore-based cancer therapeutics company which, focuses on the discovery, research, and clinical development of small molecule drugs. |
Singapore | 20 Oct 2008 | Series B Co-led the investment round. Repeat investment., Active |
|
|
|
TriReme Medical Inc TriReme Medical, Inc. (TMI) is a privately held medical device company. |
1 Oct 2010 | Series D |